Medical

blank

3D Bioprinting Vasculatures

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare. Biofabrication and bioprinting of any viable three-dimensional tissue will not be successful unless the vascularization challenge has been solved. Many organizations and talents around the world are actively tackling this challenge, but where are we exactly?

Speakers:

Andrew Hudson

blank

Andrew received his B.Sc. in Materials Science and Engineering (2014) and M.Sc. in Biomedical Engineering (2015) from Carnegie Mellon University. He is currently a Ph.D. student in Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group. The goal of Andrew’s research is to vastly improve the resolution and vascularization in 3D bioprinting to create the next generation of tissue engineered therapies such as cardiac muscle. Andrew is also a Co-Founder of FluidForm, a CMU startup that seeks to spread the FRESH 3D bioprinting technology developed in the Feinberg lab. 

Jordan Miller

blank

Jordan Miller is an Associate Professor of Bioengineering. at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his Ph.D. in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.

Prafulla Chandra

blank

Dr. Prafulla Chandra is an accomplished life science professional with current specialization in regenerative medicine, 3D bioprinting, and cell biology. He has a Ph.D. in Biotechnology from the University of Pune (India), and more than 16 years of combined scientific research experience. His unique combination of skills and experience include research, technology development and intellectual property related to biomedical and regenerative medicine products. Dr. Chandra has been working at the Wake Forest Institute for Regenerative Medicine (WFIRM) since the past 7 years under the mentorship of Dr. Anthony Atala, where his work in 3D bioprinting includes using extrusion and ink-jet based bioprinters for creating live tissues such as cartilage, bone, skin, urethra and many types of polymer scaffolds for tissue regeneration and diagnostic applications such dermal scaffolds, microfluidics-based cell culture and organ-on-a-chip systems. Additionally, adapting synthetic polymers for 3D bioprinting, creating self-expanding polymers, bioink development, stem-cells based therapies and organ-on-a-chip for screening and diagnostic applications are his other projects at WFIRM. In association with the Regenerative Medicine Clinical Center (RMCC) at WFIRM, Dr. Chandra has also worked on clinical translation of regenerative medicine products, which include an oxygen-generating wound dressing and a 3D bioprinted nasal septum cartilage. He was a core team member for validating a 3D bioprinter for clinical manufacturing and also participated in the writing of regulatory documents such as pre-IND and IND for submission to the US FDA. Prior to joining WFIRM, Dr. Chandra had worked at the New Jersey Center for Biomaterials (under the mentorship of Prof. Joachim Kohn, Director, New Jersey Center for Biomaterials, Rutgers University, NJ, USA), where his work included research in the fields of cell-biomaterial interactions, human skin tissue engineering, surface modification of polymers for enhancing cellular response and using synthetic polymer-based nanospheres for enhancing topical delivery of hydrophobic drugs. One of his research here led to the award of a US Patent (Patent No. 8414871) on which he is a co-inventor.

James (Jay) Hoying, Ph.D.

blank

James (Jay) Hoying, Ph.D. is Partner and Chief Scientist of Advanced Solutions Life Sciences (ASLS), a company pioneering solutions in tissue fabrication and biomanufacturing. Prior to joining ASLS, Dr. Hoying was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) and a Professor in the Department of Physiology at the University of Louisville. He has over 25 years of experience in basic and applied biological sciences research with a focus in tissue biology, tissue vascularization, and the microcirculation. In addition to his numerous published works, Dr. Hoying holds patents related to vascularizing tissues and related cell-based therapies; technologies that have been translated to companies, including start-ups and ASLS. Dr. Hoying is a Fellow of the American Heart Association.

Moderator:

Lehanna N. Sanders, PhD

Business Development Manager, Advanced Solutions Life Sciences

blank

Dr. Lehanna Sanders is a cellular and molecular biologist and has done research within the field of regenerative medicine for 8 years.  She received her Bachelor’s degree in Cellular, Molecular, and Development Biology from Purdue University where she completed an honors thesis project in Biomedical Engineering.  She then completed her PhD at Vanderbilt University where she published work in the area of molecular repair processes following acute cardiac injury.  During her time at Vanderbilt, she served on the Skills Development Committee for the NHLBI Progenitor Cell Biology Consortium, as well as a member of the Board of the Directors for the Life Science Tennessee-Academic Alliance.  She now works in Business Development for Advanced Solutions Life Sciences, where she is continuing to grow the field of regenerative biology through working closely with scientists and engineers to advance innovations in 3D bioprinting and biofabrication.

blank

3D Printed Orthotics and Prosthetics

One of the very first healthcare applications using 3D printing is orthotics and prosthetics. Over the years, the images of disabled children with colorful prosthetic limbs inspired impactful movements like the ENABLE community and Victoria Hand Project, as well as enumerable passionate innovators who have pushed the boundaries to increase accessibility and lower the cost of orthotics and prosthetics. However, the field of 3D printed orthotics and prosthetics has advanced significantly since the days of ENABLE hands. These advancements include not just hardware, materials, but also software, designs, 3D scanning. More importantly, there is now a significant understanding of the importance of working closely with clinicians to create a more efficient digital workflow and more evidence-based patient-centered clinical solution. In this highly anticipated webinar, we invited experts with decades of technical, business, and clinical experiences and diverse perspectives to give the attendees a 360-degree view of the current and future status of the industry.

Speakers:

Brent Wright

blank

W. Brent Wright is an ABC-Certified Prosthetist and BOC-Certified Orthotist with Eastpoint Prosthetics and Orthotics in Raleigh, NC.  He has been in the field since he started as a technician at age 16 and has seen first hand how additive technology is evolving and impacts patients not only in the US but also in the developing world. 

Brent is pioneering techniques to effectively use additive technology such as MultiJet Fusion and Selective Laser Sintering to create dynamic prostheses that are light as well as flexible.  He is excited that prosthetists have a chance to be a part of the industrial revolution where mass customization and patient outcomes collide.  

Brent is the Clinical Director of LifeNabled, a non-profit that specializes in manufacturing all new low-cost and high quality prostheses.  LifeNabled has developed a scanning app for the iPad and iPhone called Digiscan3D and also has developed a suitcase 3D printer that can be deployed anywhere in the world.

Jordi Tura

blank

CEO & founder of Xkelet, more than 15 years in 3D design, printing, and software development.

Xkelet is a Machine Learning software company. With the software (the core of the Co.) we are able to automate the entire process, from data recording to the finished product. Currently. We have done a turnkey solution* in the category of Orthopedics and Prosthetics (O&P). We want to change the current immobilization methods such as plaster and current orthotic systems, to solve the problems that come from these immobilization systems.

The immobilizations are printed with 3D printing technology and suitable for accurate measurements of the patient’s anatomy.

With Xkelet, the patient can shower and dry without problems, no longer scratching due to scaling of the skin, in case the injury includes a wound already well derived by the fracture itself as an operative process, the patient and the medical professional can see the condition of the wound instantly thanks to the design of windows. And so I do not have to wait to have a feverish process or pain, for the traumatologist to remove the cast and see what the problem is. Usually with an unfavorable state of the most advanced recovery.

Tim Fair

blank

Tim Fair is a FL Licensed and ABC Certified Prosthetist Orthotist and academic chair for the A.S. O&P Technology program at St Petersburg College.  He earned his master’s degree of Instructional Design and Technology in 2016, his bachelor’s degree in Orthotics & Prosthetics in 2006 from UTSouthwestern.  He has been actively involved in O&P Technician, Pedorthic, and Orthotic Fitter education since his arrival at St Petersburg College.  His current focus is on orthotic fabrication classes for O&P technician students.

Jorge Zuniga

blank

Dr. Zuniga is the co-director of the Center for Biomechanical Rehabilitation and Manufacturing (CBRM) at the University of Nebraska at Omaha. The mission of our center is to improve the quality of life of medically underserved populations through the offering of comprehensive rehabilitation services and the creation of low-cost medical devices for our local, national, and international communities.

Moderator: 

Jordan Elevons

blank

Jordan Pelovitz is a 3D computer graphics artist and industrial design designer, with a BFA in Industrial. He has taught 3d printing and design to the public for over five years, both locally and internationally. Throughout his career, he has worked on a variety of design applications, from automotive to aerospace, and has used a unique blend of software to accelerate innovation in both the physical and digital worlds.
To this end, he has explored techniques for developing implants using game art tools, new 3d segmentation techniques and is currently developing a low-cost, 3d printed prosthetic toolchain for manufacturing in underserved areas.

blank

Advancements in 3D Printed Anatomical Modeling

3D printed anatomical modeling is perhaps the earliest and most widespread application of additive manufacturing in healthcare. However, rapid advancements in software, materials, 3D printers, and more and more use cases are enabling further adoption by healthcare providers and more accessibility to the patients. This webinar aims to update the audience what are the latest applications by clinicians, as well as the ecosystem and new technologies that are supporting them. Since this is also a community-building event organized by Hannah Riedle, our Munich-based manager, speakers will be selected from Germany and the surrounding communities.

Organizer: 

Hannah Riedle 

3DHEALS Munich Community Manager

blank

Hannah studied Mechanical Engineer at the Technical University of Munich, where she specialized in medical technology. During her following Ph.D. at the Friedrich-Alexander-University Erlangen-Nuremberg, her research focused on the creation of digital anatomical models, additive manufacturing thereof, and as well as biomechanical and medical testing. From the topic of her Ph.D., she derived a business model which resulted in the foundation of ANAMOS in July 2020, where she is now responsible for the operational business as well as the technical development. Hannah has been the Munich-based 3DHEALS community manager since June 2017.

Speakers:

Björn Petersen 

Sales Manager DACH MEDICAL (Head of Sales) at Materialise

blank

Talk title: Software for 3D Printing at the Point of Care

Björn Petersen holds a degree in business administration and is in his actual position Sales Manager DACH MEDICAL for Materialise. He is working every day to bring mass personalization with 3D printing to the Point of Care and to increase the efficiency and quality of inpatient care. Björn is convinced that anatomical modeling is certainly an important tool to reach this goal. Before he was tackling the 3D market for Materialise, Björn gained a wide range of experience within national and international Med-Tech companies and delivered their complex medical products/services to the market.

Bernhard Dorweiler, M.D. 

Professor and Chair at the Department of Vascular and Endovascular Surgery, University Hospital Cologne, Germany

blank

Talk title: 3D-printing and anatomic modelling in Vascular Surgery

Prof. Dr. Bernhard Dorweiler is Director of the Department of Vascular Surgery at the University Medical Center of Cologne. He received his M.D. Ph.D. from Johannes-Gutenberg University in Mainz 1997 and then completed residencies for general surgery (1997-2004) and vascular surgery (2004-2006). Following a research fellowship at Columbia University New York (NY, USA) (2008-2009), he was appointed Head of the Division of Vascular Surgery, University Medical Center Mainz in 2010. In 2020, Prof. Dorweiler moved to Cologne and was appointed full professor of Vascular Surgery at the University of Cologne. Prof. Dorweiler’s research interests include complex aortic surgery, peripheral arterial surgery with a focus on reconstruction using biological material and basic science (Atherosclerosis). Since 2015, Prof. Dorweiler is interested in 3D-printing and implemented in-house 3D-Printing Labs in Mainz and currently in Cologne where anatomical 3D-prints are generated to support patient-specific precision-medicine.

Julian FĂĽrmetz, M.D. 

Section Head and Chief physician at the Department of General, Trauma and Reconstructive Surgery, Munich University Hospital, LMU, Germany

Julian FĂĽrmetz

Talk title: From 3D imaging to the OR – analysis, planning, 3D printing, and performance of osteotomies around the knee

PD Dr. Julian FĂĽrmetz graduated from the University of Leipzig in 2008. He began his training at the Department of Trauma Surgery and Orthopaedics at Leipzig University Hospital. His main interest early on was reconstructive surgery, and in 2012 he moved to the 3D surgery working group at the University of Munich as a research assistant.

In 2015, he completed his residency and then worked full-time at the Department of General, Trauma, Hand and Plastic Surgery at the University of Munich. Since 2016, he has been head of knee surgery and sports traumatology at the Musculoskeletal University Centre Munich.

His main areas of expertise are 3D deformity correction, arthroplasty, defect reconstruction and preoperative digital analysis and planning procedures. His research group was recently awarded the Science Award of the German Knee Society 2020, the Best Paper Award of the German Knee Society 2019 and the Best Paper National of the ESSKA 2020.

In addition to reconstructive surgery, Dr. FĂĽrmetz is interested in sports medicine and medical care in professional football.

Simon Enzinger, MD, DMD

Managing Senior physician at the University Clinic for Oral and Maxillofacial Surgery in Salzburg, Austria

blank

Talk Title: Advantages of 3D printed anatomical models in Maxillofacial and Craniofacial Surgery

Simon Enzinger graduated medicine 2003 and dentistry 2007 from the Medical University Innsbruck. He then joined the Department of Maxillofacial Surgery in Salzburg. Here he completed his training as an MKG surgeon. He was appointed senior physician in 2016 and has been managing senior physician at the University Hospital Salzburg since 2020. 

His main areas of expertise are tumor surgery, traumatology, microsurgery.He has been involved with technical innovations in maxillofacial surgery since 2007 and was, among other things, responsible for the development of the new surgical technique. He has been involved with technical innovations in maxillofacial surgery since 2007 and was, among other things, substantially involved in the implementation of the 1st 3D printer at the University Hospital Salzburg. Especially since the establishment of the Reference Center for Cleft patients and Craniofacial Anomalies, 3D printing has become an integral part of maxillofacial surgery.

Hannah Riedle, PhD 

Cofounder, CEO & CTO at ANAMOS

Bio: see above

Talk title: Generic anatomical models for surgical simulation

AI in 3D Printing

Artificial Intelligence in Healthcare 3D Printing

Based on popular demand, we are inviting industry and academic influencers to speak at our first “theme-based” webinar focusing on how artificial intelligence/machine learning is accelerating the 3D printing process and adoption. 

Speakers: 

Dr. Yunlong Tang

Joint lecturer in the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering Monash University

Website: https://sites.google.com/monash.edu/i-dmdlab

blank

Dr. Yunlong Tang joined the Faculty of Engineering at Monash University in Feb 2020. Currently, he is a lecturer jointly appointed by the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering.  His major research interests are in the general field of design and manufacturing, including smart manufacturing, additive manufacturing, and its related design methods, sustainable design and manufacturing, AI-aided design, CAD/CAM, design and fabrication of lattice or cellular materials. Yunlong has over nine years of international R&D experience, participating in several national research and industrial projects from China, Canada, Europe, and Singapore. He obtained his Ph.D. degree from McGill University, Canada in 2017, M.Sc. degree from Beijing University of Aeronautics and Astronautics, China in 2013, B.Sc. degree from Harbin Institute of Technology in 2010. Before he coming to Monash, he did one and half year Post-Doc research at Singapore University of Technology and Design and was working on the next generation of CAD software for AM. He is a leading developer of an open-source lattice structure design and optimization software called INTRALATTICE PRO which has been downloaded more than ten thousand times by now.

Shuchi “SK” Khurana

Founder and CEO of Addiguru

AI 3D PRinting

Shuchi “SK” Khurana is the founder and CEO of Addiguru which provides real-time monitoring solutions for Additive Manufacturing. SK has more than twenty years of experience and has commercialized six products. He also ran a start-up company for six years that was focused on social impact and women’s health. He has five granted patents and 10+ peer-reviewed publications in the field of predictive analytics and materials science. SK has an MBA and MS in Materials Science from The Ohio State University. SK got his B. Tech. from IIT Kanpur, a top engineering institute in India.

Qiang Huang, PhD

Professor, Epstein Department of Industrial and Systems Engineering; Mork Family Department of Chemical Engineering & Materials Science, University of Southern California 

Email: qiang.huang@usc.edu | Website: HuangLab.usc.edu | FACAM Blog: FACAM-online.blogspot.com

blank

Dr. Qiang Huang is currently a Professor at the Daniel J. Epstein Department of Industrial and Systems Engineering, University of Southern California (USC), Los Angeles. His research focuses on AI and Machine Learning for Manufacturing, in particular, Machine Learning for Additive Manufacturing (ML4AM). He was the holder of Gordon S. Marshall Early Career Chair in Engineering at USC from 2012 to 2016. He received the National Science Foundation CAREER award in 2011 and IEEE Transactions on Automation Science and Engineering Best Paper Award from IEEE Robotics and Automation Society in 2014.

He is Department Editor for IISE Transactions, Associate Editor for ASME Transactions, Journal of Manufacturing Science and Engineering, and a member of the Editorial Board for Journal of Quality Technology. He also served as an Associate Editor for IEEE Transactions on Automation Science and Engineering and for IEEE Robotics and Automation Letters.

Davide Marini

Co-founder and CEO, Inkbit

blank

Davide is a co-founder and CEO at Inkbit. He was previously co-founder and CEO at Firefly BioWorks, an MIT startup that commercialized a novel assay for miRNA detection, based on functional microparticles manufactured by flow lithography. Davide led Firefly from inception to its acquisition by Abcam. He obtained his BS in Industrial Engineering from Politecnico of Milan and his Ph.D. in Mechanical Engineering from MIT.

Moderator: 

Tuan TRANPHAM

Chief Revenue Officer (CRO) at AREVO 

Tuan Tranpham

Tuan TranPham is Chief Revenue Officer at AREVO and prior to that he spend 18 years working for six of the largest 3D printing companies, such as Z Corp, 3D Systems, Objet, Stratasys, Arcam (a GE company) and Desktop Metal.

Tuan possesses a unique perspective and insight on 3D printing applications, challenges, opportunities, technologies and trends. Tuan is extensively connected within the 3D printing industry and has over 21,000+ LinkedIN followers.  He was recently presented a Distinguished INnovator Operators award, known as “the DINO Award” within the 3D Printing Industry.  

Tuan earned a Business (Export) Engineering degree from the Danish Technical University (DTU) and gained business experience while working in Denmark, England, Hong Kong, Japan and the United States.  

He speaks Danish, English and Vietnamese. Tuan is based in Greater Boston, MA where he lives with his wife Thao and son Sebastien.

Fun fact: He has traveled and competed all â€ś7 Wonders of the World” – both the new and the old ones.

blank

3DHEALS Ohio

3DHEALS Ohio: Hidden Gems

Ohio is perhaps one of the most overlooked healthcare innovation hubs. In this webinar focusing on 3DHEALS Ohio community, we are featuring experts from academia and local businesses who are working on cool things that (you may not realize) are happening in Ohio.

Speaker info:

Andrew Hudson

blank

Andrew received his B.Sc. in Materials Science and Engineering (2014) and M.Sc. in Biomedical Engineering (2015) from Carnegie Mellon University. He is currently a Ph.D. student in Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group. The goal of Andrew’s research is to vastly improve the resolution and vascularization in 3D bioprinting to create the next generation of tissue engineered therapies such as cardiac muscle. Andrew is also a Co-Founder of FluidForm, a CMU startup that seeks to spread the FRESH 3D bioprinting technology developed in the Feinberg lab. 

Interview with Andrew Hudson, Co-Founder of Fluidform

The Yellow Brick Road of 3D Bioprinting (Part 1)

The Yellow Brick Road of 3D Bioprinting (Part 2): Soft Is Hard

The Yellow Brick Road of 3D Bioprinting (Part 3): Maturation

3D Bioprinting: The Yellow Brick Road (Part 4)

Keith Grafmeyer

blank

Keith Grafmeyer graduated from the University of Rochester with a BS in Biomedical Engineering and is currently the Director of Product Development at VisionAir Solutions, a spinout of the Cleveland Clinic.  He has been working in medical device startups in the Cleveland-area for about 6 years while holding management roles in regulatory affairs and product development.  So far in his career, Keith has brought two patient-specific medical device systems to market in orthopedics and interventional pulmonology with 7 FDA 510(k) clearances.  The orthopedic system was acquired in 2018 by Arthrex.  It has now treated tens of thousands of patients as their Arthrex VIP shoulder arthroplasty product.  

In his current role, Keith oversaw the development and product launch of a system to treat airway obstruction with proprietary software and patient-specific silicone airway stents.  The company is working on a new version of this software as well as implants to treat other complex problems in interventional pulmonology.

Overall, Keith has had the unique experience of managing the development, regulatory clearance, and market launch of products that contain proprietary software and patient-specific treatment deliverables manufactured using 3D-printing technology.

Dave Pierson

Senior Design engineer at Manufacturing Advocacy & Growth Network (MAGNET)

Dave Pierson

Dave Pierson is a Senior Design Engineer for MAGNET and a notable figure in the advanced manufacturing community. He has 23 years of varied and practical additive manufacturing training experience as well as 40 years of experience in mechanical and electric engineering and programming. Pierson regularly develops and delivers training curriculum and trains operators, students, and engineers on past and present additive techniques. His experience covers seven AM standards categories as set by the American Society for Testing and Materials.

David Dean

Departments of Plastic and Reconstructive Surgery and Materials Science and Engineering at The Ohio State University

David Dean

David Dean’s research focuses on medical procedures and devices primarily related to musculoskeletal reconstructive surgery. His PhD thesis presented a novel, template-based method for the production of average 3D surface images of organs such as the skull. His postdoctoral research at the Institute of Reconstructive and Plastic Surgery (New York University, New York, NY) used average skull images as targets for surgical simulation and intra-operative guidance. In July 1994, Dr. Dean joined Case Western Reserve University (Cleveland, OH) where he began using average skull images to design and fabricate cranial implants in the Department of Neurological Surgery. Indeed, Dr. Dean was the first person to use an anatomical template to design and 3D print a patient-specific cranial implant, a procedure that is now standard-of-care. Since the mid-1990’s Dr. Dean’s research has expanded to incorporate techniques from the field of regenerative medicine, including biomaterials, skeletal progenitor cells, and cell-signaling proteins and molecules in the search for a bone tissue engineering (i.e., bone substitute) strategy. In 2013 Dr. Dean’s primary appointment moved to the Department of Plastic and Reconstructive Surgery at The Ohio State University (Columbus, OH) and, currently, the Materials Science and Engineering Department. At Ohio State University he leads the Osteo Engineering Lab (www.OsteoEngineering.com) where novel bone tissue engineering research uses 3D printed, resorbable, solid-cured polymers as well as bioprinted, cell-laden, hydrogels. He is also working on the 3D printing of two biometals, NiTi and a resorbable, patent-pending Mg alloy. Both are being used to develop stiffness-matched, skeletal fixation devices. Taken together, these technologies portend significant improvements in musculoskeletal reconstructive surgical outcomes.

Moderator: 

Dr. Justin Baker

Dr. Justin Baker

Dr. Justin Baker graduated magna cum laude and with university honors in mechanical engineering from Brigham Young University (BYU). Dr. Baker subsequently earned his Ph.D. in Bioengineering from the University of Utah. A postdoctoral fellowship at the Cleveland Clinic brought him and his family to Cleveland in 2010. Since then Dr. Baker has worked for a number of local start-up and mid-size medical device companies, and his family has grown to include six children. In 2014, Dr. Baker was certified in Regulatory Affairs (RAC). He currently serves as the Vice President for Research and Development for Viscus Biologics, collagen, and natural polymers-based biomaterials and medical device company. Dr. Baker has been the Cleveland Community Manager for 3DHEALS since 2018.

blank

blank

3DHeals Melbourne – 3D MedTech Innovation

3DHeals Melbourne is returning in 2021 to highlight local collaborative innovations in health care 3D technologies and to provide a virtual platform to foster crosstalk between clinicians, academia, and industry. The focus for this event will be on the real-world applications of biomedical engineering as we will hear from leading experts in the fields of 3D printing, 3D modeling/digital design, medical devices, and implants, followed by a discussion panel to breakdown similar challenges that lie ahead and how best to synergize research and development efforts moving forward. 

3DHeals Melbourne welcomes all who are interested to learn more of the latest developments, practical applications, and future explorations of these exciting 3D medical technologies and how they can help shape the future of patient care.

Speaker info:

William Harley

William Harley

William Harley graduated with honors in medical biotechnology from the University of New South Wales. Currently, he is undertaking a Ph.D. at the University of Melbourne in acoustophoretic bioprinting. Stemming from his research experience in biomaterials, stem cells, and nanofabrication, he is driven by the clinical translation of personalized regenerative medicine. He is passionate about the innovation of 3D printing in healthcare and is determined to orchestrate a series of 3D HEALS events to engage in the Australian community.

Mark Roe

Managing Director of Fusetec

Mark Roe

Mark Roe, along with his business partner John Budgen founded Fusetec in April 2017, the business had a somewhat unconventional beginning. “When I was introduced to advanced manufacturing, the theory behind Industry 4.0 was compelling. I could really see a future in it,” said Roe. Once back in Australia, Mark considered the three major manufacturing industries in South Australia: aerospace, defense, and medical. He quickly landed on medical. “By opting to work in the medical industry, we could develop our own IP, with global applications.” It was then that he started canvassing medical professionals and academia to pinpoint that all-elusive problem to solve. The three most commonly cited issues were a lack of cutting guides, medical implants, and patient-specific models. However, he was not keen to pursue a business model based on personalized manufacturing. Mark leads the management team and passionately drives our Research & Development team, collaborating with Universities, Medical professionals, and Government entities worldwide.

Prof. Peter Lee

Professor in the Department of Mechanical Engineering at University of Melbourne/Director of ARC CMIT

blank

Prof. Peter Lee obtained his BEng in Mechanical Engineering (1st Class Hons. 1991) and PhD (1996) in Bioengineering from the University of Strathclyde, UK, and continued his post-doc in the same university from 1996–1998.

Professor Peter Lee is the Director of the Australian Research Council (ARC) Training Centre for Medical Implant Technologies and the Chief Investigator in the ARC Training Centre for Personalised Therapeutic Technologies. As Director of the ARC Training Centre for Medical Implant Technologies, he leads the largest industry-university-hospital partnership in Australia focusing on orthopaedic and maxillofacial implants to train a new generation of interdisciplinary engineers in biomechanics, materials and manufacturing for the orthopaedic and maxillofacial implant industry. He joined the University of Melbourne, Australia, as a Senior Lecturer in 2008, and was promoted to an Associate Professor in 2011 and a Professor in 2015. Since then he has held several leadership positions including Deputy Head and Acting Head of Department of Mechanical Engineering, and currently as the Deputy Head (Research) of Department of Biomedical Engineering and leads the Cell and Tissue Biomechanics Laboratory in Engineering, where his research aims to better understand the behaviour of biological cells and tissues under mechanical forces. He has authored more than 140 publications in journals, conference proceedings and books. He is a regular reviewer for journals and grant bodies and currently the Deputy Editor for Journal of Orthopaedic Surgery and Research (Springer Nature), and Associate Editor for Frontiers in Pharmacology (Translational Pharmacology).

A/Prof. Kate Fox

Associate Dean of Higher Degrees by Research/ and Associate Professor within the School of Electrical and Biomedical Engineering at RMIT

blank

Kate Fox is an Associate Professor in the School of Electrical and Biomedical Engineering. Kate is a biomedical engineer with significant experience and expertise in coatings and implant fabrication for orthopedic applications. Prior to joining RMIT, she was part of the Bionic Eye Project working to develop a high acuity diamond electrode capable of electrically stimulating retinal tissue. She is a reformed patent attorney and can advise on the patentability of research. Kate is committed to the real-world application of biomedical engineering and was shortlisted for the AFR 2018 Emerging Leader in Higher Education Award. Kate is experienced in working in highly complex, transdisciplinary projects, coordinating research teams, and providing the surgical integration necessary to transition an engineered product into a surgically feasible product. She has successfully attained over A$6M direct and in-kind funding. Kate is CI in the ARC ITTC in Additive Biomanufacturing and a 2019-2020 Superstar of STEM.

Dr. Lindsay Bussau BSc (Hons), PhD

Applications and Customer Support Manager, Optiscan Pty Ltd

blank

The talk will discuss endomicroscopy and the basics of Optiscan’s handheld fibre-optic confocal microscope. Dr. Bussau will demonstrate the Optiscan FIVE2 (Viewnvivo) handheld confocal imaging system and will discuss the potential for use of confocal endomicroscopy to image tissue structure in vivo. Dr Bussau did his post-doctorate research on confocal laser fiber optic imaging and has 25 years of experience with the technology.

Dr. Yunlong Tang

Joint lecturer in the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering Monash University

blank

Dr. Yunlong Tang joined the Faculty of Engineering at Monash University in Feb 2020. Currently, he is a lecturer jointly appointed by the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering.  His major research interests are in the general field of design and manufacturing, including smart manufacturing, additive manufacturing, and its related design methods, sustainable design and manufacturing, AI-aided design, CAD/CAM, design and fabrication of lattice or cellular materials. Yunlong has over nine years of international R&D experience, participating in several national research and industrial projects from China, Canada, Europe, and Singapore. He obtained his Ph.D. degree from McGill University, Canada in 2017, M.Sc. degree from Beijing University of Aeronautics and Astronautics, China in 2013, B.Sc. degree from Harbin Institute of Technology in 2010. Before he coming to Monash, he did one and half year Post-Doc research at Singapore University of Technology and Design and was working on the next generation of CAD software for AM. He is a leading developer of an open-source lattice structure design and optimization software called INTRALATTICE PRO which has been downloaded more than ten thousand times by now.

Tam C. Nguyen

Associate Professor and Deputy Director of Research at St Vincent’s Hospital Melbourne

blank

Associate Professor Tam Nguyen has over 20 years of working in the healthcare, health & medical research environment including tertiary teaching hospitals and research institute across Australia.

Tam is the Deputy Director of Research at St Vincent’s Hospital Melbourne, one of the largest tertiary teaching and research hospitals in Melbourne – responsible for the organisation’s research strategy, research ethics and governance, clinical trials, research innovation and development.

Tam serves as non-executive director and advises several medtech and health tech start-ups on clinical and commercialisation strategy. He is a regular invited speaker on a broad range of topics at national and international conferences. He holds academic appointment with Melbourne University’s Medical School and Monash University’s Medical School – two of the world top 30 (and APAC top 5) medical schools.

blank